Profound Medical (TSE:PRN) Trading Up 0.1% – Still a Buy?

Profound Medical Corp. (TSE:PRN)’s share price was up 0.1% during mid-day trading on Tuesday . The company traded as high as C$12.00 and last traded at C$11.71. Approximately 7,128 shares were traded during mid-day trading, a decline of 0% from the average daily volume of 7,141 shares. The stock had previously closed at C$11.70.

Analyst Ratings Changes

Separately, Raymond James upgraded shares of Profound Medical to a “strong-buy” rating in a research note on Saturday, November 9th.

Profound Medical Stock Up 0.1 %

The company has a debt-to-equity ratio of 16.95, a current ratio of 8.61 and a quick ratio of 14.98. The business’s 50 day moving average is C$10.78 and its 200-day moving average is C$11.61. The company has a market cap of C$286.66 million, a PE ratio of -7.05 and a beta of 0.81.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.